/Cooper%20Companies%2C%20Inc_%20sign%20on%20building-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
Cooper Companies has significantly underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.
/Idexx%20Laboratories%2C%20Inc_%20phone%20and%20logo-%20by%20T_Schneider%20via%20Shutterstock.jpg)
IDEXX Laboratories has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.
/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
Despite ResMed’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/Intuitive%20Surgical%20Inc%20logo%20on%20phone-by%20Ralf%20Liebhold%20via%20Shutterstock.jpg)
Intuitive Surgical has outperformed the broader market by a wide margin over the past year, and analysts are moderately optimistic about the stock’s prospects.
/Hologic%2C%20Inc_%20%20magnified%20-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Hologic has lagged the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/GE%20HealthCare%20Technologies%20Inc%20sign%20on%20building%20-by%20Poetra%20RH%20via%20Shutterstock.jpg)
GE HealthCare is poised to reveal its second-quarter earnings results this month, and analysts foresee a modest uptick in its bottom-line figure.